A new review of research bringing together patient, carer and public views of cell and gene therapies has highlighted a need for appropriate education to better inform patients.
A new educational framework and toolkit will be launched in the UK and Ireland this week to improve training and guidance for those providing palliative and end of life care for children.
A recently published study by scientists from King's College London, University of Oxford, University of Glasgow and University of Birmingham sheds light on the mechanism of action of an exciting new class of drugs.
The Allergy, Asthma and Clinical Immunology centre in Birmingham is officially world class after achieving prestigious international recognition.
People with rheumatoid arthritis could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores.
Researchers studying a group of UK healthcare workers discovered that non-white individuals recovering from COVID-19 displayed higher antibody levels than white individuals.
Dr Katja Gehmlich has been jointly awarded a three-year research grant from the Medical Research Council to understand how cardiac mechano-sensing works to help develop therapies for heart failure.
New insights into the mechanisms behind how cancer-causing agents in the environment active genetic recombination in DNA could help to better predict which individuals are more susceptible to developing the disease.
A new and unique real-time simulation-based medical training programme developed by Dr Punith Kempegowda has helped enhance medical students' and junior doctors' learning experience and connecting them across the globe.
People across the Global South living with cardiovascular diseases and their risk factors may be missing potentially life-saving treatments because measures used to gauge their quality of healthcare are inadequate.
Dr Ildem Akerman is the recipient of the highly respected RD Lawrence Fellowship Award from Diabetes UK for her research in identifying factors important to generate beta cells from stems cells in a laboratory.
Routine testing patients for COVID-19 before major surgery could reduce the risk of respiratory complications and save lives, a new study reveals.